Literature DB >> 11249718

Edaravone Mitsubishi-Tokyo.

R Tabrizchi1.   

Abstract

Mitsubishi-Tokyo (formerly Mitsubishi Chemical) is developing edaravone (norphenazone), a free radical scavenger, for the potential treatment of cardiovascular disease, cerebrovascular ischemia and cerebral edema. By February 2000, edaravone had been filed in Japan for the treatment of acute brain infarction, and was in phase III trials for subarachnoid hemorrhage [365460]. The compound blocks the action of the lipoperoxide, 15-HPETE, which normally increases with age and may be associated with neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11249718

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  12 in total

Review 1.  Post-stroke inflammatory response: effects of stroke evolution and outcome.

Authors:  Kiat T Tan; Gregory Y H Lip; Andrew D Blann
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

2.  Scavenging free radicals improves endothelial dysfunction in human coronary arteries in vivo.

Authors:  Jun-ichi Oyama; Shinji Satoh; Nobuhiro Suematsu; Toshiaki Kadokami; Toyoki Maeda; Masahiro Sugano; Naoki Makino
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

3.  Survivin is involved in the anti-apoptotic effect of edaravone in PC12 cells.

Authors:  Xue-Yuan Liu; Ling-Ling Yao; Yu-Juan Chen; Bei-Bei Tao; Yong-Chun Yu; Wei-Hong Bian; Jing Yu; Yong-Gang Wang
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

Review 4.  1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.

Authors:  Astrida Velena; Neven Zarkovic; Koraljka Gall Troselj; Egils Bisenieks; Aivars Krauze; Janis Poikans; Gunars Duburs
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543

5.  Edaravone improves spatial memory and modulates endoplasmic reticulum stress-mediated apoptosis after abdominal surgery in mice.

Authors:  Ayong Tian; Hong Ma; Rongwei Zhang; Yong Cui; Chengfu Wan
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

6.  Fructose-1,6-bisphosphate does not preserve ATP in hypoxic-ischemic neonatal cerebrocortical slices.

Authors:  Jia Liu; Kiyoshi Hirai; Lawrence Litt
Journal:  Brain Res       Date:  2008-08-12       Impact factor: 3.252

7.  Renoprotective effect of edaravone in acute limb ischemia/reperfusion injury.

Authors:  İlker İnce; İlker Akar; Akgül Arıcı
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

8.  Cobalt-Catalyzed Suzuki Biaryl Coupling of Aryl Halides.

Authors:  Soneela Asghar; Sanita B Tailor; David Elorriaga; Robin B Bedford
Journal:  Angew Chem Int Ed Engl       Date:  2017-11-28       Impact factor: 15.336

9.  Therapeutic time window for edaravone treatment of traumatic brain injury in mice.

Authors:  Kazuyuki Miyamoto; Hirokazu Ohtaki; Kenji Dohi; Tomomi Tsumuraya; Dandan Song; Keisuke Kiriyama; Kazue Satoh; Ai Shimizu; Tohru Aruga; Seiji Shioda
Journal:  Biomed Res Int       Date:  2013-04-10       Impact factor: 3.411

10.  Density functional theory (DFT) study of edaravone derivatives as antioxidants.

Authors:  Rosivaldo S Borges; Auriekson N Queiroz; Anna P S Mendes; Sanderson C Araújo; Luiz C S França; Edna C S Franco; Walace G Leal; Albérico B F Da Silva
Journal:  Int J Mol Sci       Date:  2012-06-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.